Fox Chase Cancer Center Nurse to Moderate a Series of Nursing Videos
PHILADELPHIA (May 28, 1999) -- Fox Chase Cancer Center nurse Susan Weiss Behrend, RN, MSN, AOCN, will moderate a video series designed to build patient-care skills through scientific updates, expert interviews, and "best practice" highlights. Entitled Oncology Nursing Today, the leading edge series has been developed by the Oncology Nursing Society (ONS).
Ms. Behrend is an educational consultant at Fox Chase. She will moderate the four-part series which will address the oncology trends that challenge today's specialty nurses as they work with physicians and patients to optimize care and outcomes.
Topics for the 1999 series include: Basic Genetics for the Oncology Nurse, Pharmacology 2000 for the Oncology Nurse, Managing Physical Assessments and Supportive Cancer Care, and Complementary Therapy: Options for Your Patients.
The Oncology Nursing Society is a national organization of more than 27,000 oncology nurses and other healthcare professionals committed to promoting excellence in oncology nursing and quality cancer care. ONS is the largest professional membership oncology association in the world.
Fox Chase Cancer Center is one of 35 National Cancer Institute-designated comprehensive cancer centers in the nation. The Center's activities include basic and clinical research, prevention, detection and treatment of cancer and community outreach programs.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.